These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 9307285

  • 21. 31P magnetic resonance spectroscopy as a predictor of efficacy in photodynamic therapy using differently charged zinc phthalocyanines.
    Bremner JC, Wood SR, Bradley JK, Griffiths J, Adams GE, Brown SB.
    Br J Cancer; 1999 Oct; 81(4):616-21. PubMed ID: 10574246
    [Abstract] [Full Text] [Related]

  • 22. Investigation of human serum albumin (HSA) binding specificity of certain photosensitizers related to pyropheophorbide-a and bacteriopurpurinimide by circular dichroism spectroscopy and its correlation with in vivo photosensitizing efficacy.
    Chen Y, Miclea R, Srikrishnan T, Balasubramanian S, Dougherty TJ, Pandey RK.
    Bioorg Med Chem Lett; 2005 Jul 01; 15(13):3189-92. PubMed ID: 15936945
    [Abstract] [Full Text] [Related]

  • 23. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
    Colussi VC, Feyes DK, Mulvihill JW, Li YS, Kenney ME, Elmets CA, Oleinick NL, Mukhtar H.
    Photochem Photobiol; 1999 Feb 01; 69(2):236-41. PubMed ID: 10048316
    [Abstract] [Full Text] [Related]

  • 24. Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.
    Wang HW, Rickter E, Yuan M, Wileyto EP, Glatstein E, Yodh A, Busch TM.
    Photochem Photobiol; 2007 Feb 01; 83(5):1040-8. PubMed ID: 17880498
    [Abstract] [Full Text] [Related]

  • 25. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
    Anderson CY, Freye K, Tubesing KA, Li YS, Kenney ME, Mukhtar H, Elmets CA.
    Photochem Photobiol; 1998 Mar 01; 67(3):332-6. PubMed ID: 9523532
    [Abstract] [Full Text] [Related]

  • 26. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
    Sitnik TM, Henderson BW.
    Photochem Photobiol; 1998 Apr 01; 67(4):462-6. PubMed ID: 9559590
    [Abstract] [Full Text] [Related]

  • 27. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
    Zupkó I, Kamuhabwa AR, D'Hallewin MA, Baert L, De Witte PA.
    Int J Oncol; 2001 May 01; 18(5):1099-105. PubMed ID: 11295062
    [Abstract] [Full Text] [Related]

  • 28. Synthesis and biological evaluation of 173-dicarboxylethyl-pyropheophorbide-a amide derivatives for photodynamic therapy.
    Zhu W, Wang LX, Chen DY, Gao YH, Yan YJ, Wu XF, Wang M, Han YP, Chen ZL.
    Bioorg Med Chem Lett; 2018 Sep 01; 28(16):2784-2788. PubMed ID: 29279274
    [Abstract] [Full Text] [Related]

  • 29. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy.
    Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN.
    J Am Chem Soc; 2003 Jul 02; 125(26):7860-5. PubMed ID: 12823004
    [Abstract] [Full Text] [Related]

  • 30. Photodynamic therapy: a means to enhanced drug delivery to tumors.
    Snyder JW, Greco WR, Bellnier DA, Vaughan L, Henderson BW.
    Cancer Res; 2003 Dec 01; 63(23):8126-31. PubMed ID: 14678965
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
    Chin W, Lau W, Cheng C, Olivo M.
    Int J Oncol; 2004 Sep 01; 25(3):623-9. PubMed ID: 15289863
    [Abstract] [Full Text] [Related]

  • 32. Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.
    Wang HW, Putt ME, Emanuele MJ, Shin DB, Glatstein E, Yodh AG, Busch TM.
    Cancer Res; 2004 Oct 15; 64(20):7553-61. PubMed ID: 15492282
    [Abstract] [Full Text] [Related]

  • 33. Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice.
    Thomas N, Tirand L, Chatelut E, Plénat F, Frochot C, Dodeller M, Guillemin F, Barberi-Heyob M.
    Photochem Photobiol Sci; 2008 Apr 15; 7(4):433-41. PubMed ID: 18385885
    [Abstract] [Full Text] [Related]

  • 34. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX.
    Bellnier DA, Greco WR, Loewen GM, Nava H, Oseroff AR, Dougherty TJ.
    Lasers Surg Med; 2006 Jun 15; 38(5):439-44. PubMed ID: 16634075
    [Abstract] [Full Text] [Related]

  • 35. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
    Tirand L, Frochot C, Vanderesse R, Thomas N, Trinquet E, Pinel S, Viriot ML, Guillemin F, Barberi-Heyob M.
    J Control Release; 2006 Mar 10; 111(1-2):153-64. PubMed ID: 16423422
    [Abstract] [Full Text] [Related]

  • 36. Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos.
    Vargas A, Pegaz B, Debefve E, Konan-Kouakou Y, Lange N, Ballini JP, van den Bergh H, Gurny R, Delie F.
    Int J Pharm; 2004 Nov 22; 286(1-2):131-45. PubMed ID: 15501010
    [Abstract] [Full Text] [Related]

  • 37. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
    Chen B, Zupkó I, de Witte PA.
    Int J Oncol; 2001 Apr 22; 18(4):737-42. PubMed ID: 11251168
    [Abstract] [Full Text] [Related]

  • 38. Tolyporphin: a natural product from cyanobacteria with potent photosensitizing activity against tumor cells in vitro and in vivo.
    Morlière P, Mazière JC, Santus R, Smith CD, Prinsep MR, Stobbe CC, Fenning MC, Golberg JL, Chapman JD.
    Cancer Res; 1998 Aug 15; 58(16):3571-8. PubMed ID: 9721863
    [Abstract] [Full Text] [Related]

  • 39. Trisulfonated porphyrazines: new photosensitizers for the treatment of retinal and subretinal edema.
    van Lier JE, Tian H, Ali H, Cauchon N, Hasséssian HM.
    J Med Chem; 2009 Jul 23; 52(14):4107-10. PubMed ID: 19514748
    [Abstract] [Full Text] [Related]

  • 40. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma.
    Bhuvaneswari R, Gan YY, Yee KK, Soo KC, Olivo M.
    Int J Mol Med; 2007 Oct 23; 20(4):421-8. PubMed ID: 17786271
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.